chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received my first dose of Moderna Covid Vaccine about 10;20 am on Feb 18, 21. BY afternoon my arm hurt at injection site but otherwise I had not noticed any reaction. When I went to bed I had no reason to examine my body in a mirror. At 5:30 am Feb 19 when I was getting dressed I saw a large flat red rash covering the top portion of my chest on both side, wider area on the right side where I received shot. It did not itch. I had no other symptoms on the list. However I had the beginnings of a migraine. I took the migraine medication about an hour later (which interacts with a large number of meds).  I monitored the rash and it faded gradually and was gone by evening. I have no idea when it began since I did not look in the mirror the day of the 18th.
Rec'd Immunization 11/27/01 no fever; mother administered Tylenol every six hours for the first thirty-six hours after Immunization. Developed cough and low grade fever 12/03/2002. Mother administered Robitussin infant drops for cough and increased chest congestion. Had poor appetite until 12/06/2001. On 12/06/2001  late in evening, pt. threw her head back, eyes rolled back & mouth was contorted. She had several episodes of this, Mother took her to the hospital-brain scan-negative and plans to schedule EEG soon. Pt. was not observed having seizure activity in the hospital and was not placed on any medication.
No additional AE reported; a dose of MMR II was administered intramuscularly; This spontaneous report has been received from a registered pharmacist referring to a patient of an unreported age and gender. The patient's pertinent medical history, drug reactions or allergies, and concomitant therapies were not reported.  On 18-MAR-2022, the patient was administered 0.5 milliliters (ml) of measles, mumps, and rubella (wistar RA 27-3) virus vaccine, live (M-M-R II) intramuscularly for prophylaxis (dose number, vaccination scheme, anatomical location, lot number, and expiration date were not provided) (incorrect route of product administration). No additional adverse events (AE) were reported.
My heart beat gets really slow to where it feels like I?m panicking and can?t breathe correctly. My vision will also get fuzzy. My period didn?t come for two months.
Re: Chest Pains, and Chest Tightness/Pressure, and Abnormal EKG after receiving the J&J COVID Vaccine  On November 8, 2021, I received the Johnson & Johnson COVID-19 Vaccine.   I initially felt okay followed by the seemingly common flu like symptoms and body aches later in the day on November 8, 2021.  On or about November 9, 2021, I began having some chest pains and pressure in my chest and it was sore. I have never experienced these pains/pressure and tightness before.  I contacted my cardiologist and made an appointment to come see her.  She completed an echocardiogram (ultrasound) and things were unremarkable.  My cardiologist told me that if the chest pain and tightness continued for a few more days without resolving that she would like to send me for some labs to check for biomarkers.  I contacted my Cardiologist on Monday Nov 15, 2021 and let her know that while the tightness and chest pains had improved some I still had chest pains.  My cardiologist sent me for labs, one of which was the d-dimer test.  I took the labs on or about Wednesday, Nov 17, 2021.  On Friday afternoon, November 19, 2021, my cardiologist called me and let me know that one of the labs (d-dimmer) had come back well above the normal range and she asked me to go to Hospital and get a CT scan right away to ensure there was not blood clotting.  Friday, November 19, 2021, early evening I went to Hospital and relayed what my Cardiologist had found in the D-Dimer test and told them she had asked me to get a CT-Scan.  The hospital Docs wanted to retest the d-dimer to see if the test had been wrong or false.  They drew blood and ran the d-dimer and it came back at the same 1.6 level that my cardiologist had seen from my previous test.  The Hospital also ran an EKG test and it came back with abnormality.  They ran the EKG test a second time and it came back unremarkable.  The Hospital gave me a CT-Scan and found no blood clot. Hospital discharged me after the CT-scan but gave me a copy of the abnormal EKG they found very concerning and told me to give it to my Cardiologist because it could be an indication that there may be a problem.
Information has been received from a physician concerning an 8 year old male who on 01-JAN-2004 and 14-JUN-2006 was vaccinated with first and second doses of MMR II (lot# not reported). On 01-JAN-2010 the patient experienced parotitis. At the time of the report, the patient's outcome was unknown. Follow up information has been received from the physician who reported that the 8 year old patient (also reported as 9 year old at onset date) experienced mumps on 16-JAN-2010. The date diagnosed was reported as 17-JAN-2010. The patient had left parotitis. On 17-JAN-2010, the blood work test showed IgM <1:10, IgG 7.7 and serum amylase 606. At the time of the report the patient's outcome was unknown. No further information is available.
pt received wrong vaccine pt needed to receive dtap and ipv alone but received kinrix and wrong for pt age at time of vaccine
2in x 2in circular red warm area left deltoid. Fever 101 degrees. Ice, BENADRYL, ADVIL.
6 hours after vaccine developed bilateral upper extremity numbness and weakness.  R arm symptoms resolved in 30 minutes.  L arm symptoms persist.  Awoke with a headache 2/27/21 with headache-severe R sided temple.  Had brief urinary urgency but did not urinate.  L arm weakness and numbness persistent. Arm function returned but has persistent inability to move / use L hand and has loss of sensation L hand /forearm in glove distribution to mid forearm.
cold, cough, fever starting 25MAR93; 2 days later vomited x 3, poor appetite; seen by MD 28MAR93; dx lt OM, gastroenteritis; had ear infect again on 24JAN93 & 9FEB94 resolved on 2MAR93;
Patient received MenB2 at 9:13 am, at 5:30 pm parent took to ER. Per ER report back/neck/sore throat/headache, muscle aches, fever, chills. "Felt tingling in neck/back" pain score 7. Labs, x-ray completed, IV ketorolac and Ceftriaxone given. Patient discharged to home at 9:40pm. Symptoms improved. 8/28/18 call to patient - much better, "feels stiff" went to school today.
Administration error.  Patient received 0.3 ml instead of 0.5 ml.  Per CDC guidelines dose was not repeated.
15-20 minutes after vaccine, pain in chest with deep breath, no trouble breathing, O2 sat 99%,  felt need to cough, hoarseness. Felt better but then  about 45 minutes began to feel worse  Followed up with family MD prescribed albuterol inhaler.  1/29/21 seen in  ER for nausea, fatigue, body aches and weakness
sore arm; This is a spontaneous report received from a non-contactable reporter (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
ADMINSITERED PAST THE CURRENT REFRIGIRATION BEYOND USE DATE AS LISTED IN EUA
Information has been received from a licensed visiting nurse concerning a female who on 13-JUL-32-2007 was vaccinated with a 0.5ml SC dose of MUMPSVAX (Lot# 652337/1187F) into the left the left upper arm. On 13-JUL-2007 the patient developed symptoms of rash, fatigue and a feverish feeling, which were noted to have diminishing on 20-JUL-2007. Unspecified medical attention was sought. The patient's recovery status was unknown. There was no product quality complaint. Additional information has been requested.
I had no side effects from a 1st dosage of the Covid-19 vaccine except a little soreness at the injection site.  I had a 2nd dose of Pfizer Covid -19 vaccine at 11:30 a.m. on 3/31/21.  Afterwards I went for a walk, came home, and fell asleep.  I awoke at approximately 5:30 p.m., about six hours following the 2nd dose of vaccine, to an awful tone in both ears. This was most severe during the first 48 hours.  This has continued as of this writing.  At this point, I would self-diagnose this as some level of tinnitus.  I have no previous history of tinnitus.  This is awful -- need help!
vomiting; chills; fever; headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (1st dose, Manufacturer unknown), for Covid-19 immunization; Covid-19 vaccine (2nd dose, Manufacturer unknown), for Covid-19 immunization; Covid-19 vaccine (Dose 3, booster, Manufacturer unknown), for Covid-19 immunization. The following information was reported: VOMITING (non-serious), outcome "unknown"; CHILLS (non-serious), outcome "unknown"; PYREXIA (non-serious), outcome "unknown", described as "fever"; HEADACHE (non-serious), outcome "unknown".  Additional information: It was reported that the patient experienced all the events the day following 4th Pfizer COVID booster vaccine at 6pm the day prior.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration expired vaccines) in an 80-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 059H21A) for COVID-19 vaccination. No Medical History information was reported. On 31-Mar-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 31-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration expired vaccines). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administration expired vaccines) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The vial was initially stored in the refrigerator on 17 Mar 2022. The vials did not undergo any temperature excursion. No treatment medications were reported. Vial was initially stored in the refrigerator on 17-Mar-2022. Vial did not undergo any temperature excursions.
Sent home from work early complaining of feeling unwell one day after receiving vaccine.  Witnessed agonal breathing while sitting in chair that same afternoon.  Resuscitation unsuccessful.  Autopsy showed hemopericardium due to ruptured myocardial infarct due to coronary artery thrombosis due to coronary artery atherosclerosis.  No evidence of anaphylaxis or myocarditis.
9 days after shot my arm is still red and swollen   I was very sickly for a few days afterwards
Myalgia Soreness at injection site and extreme fatigue Narrative: Dose 1: Soreness at injection site and extreme fatigue
Right leg with pain that became increasingly worse. Leg now is numb, with excrutiating intermittent sharp pain.  Cannot bear wt.on right leg.
Information has been received from a registered nurse referring to a patient of unknown age and gender. On 29-APR-2015 the patient was vaccinated with a dose of ROTATEQ (oral, strength, lot#, dose were unspecified) that was stored improperly. No adverse effects reported. Additional information has been requested.
Face became swollen, slight temperature, experienced projectile vomiting and then dry heaves.  Attempted to take OTC medication but was not able to hold down.  Felt better approximately 24 hours later.
Administered expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine ) in a 32-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 32030BD) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine ). On 29-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine ) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant use were reported No Treatment were reported It was reported that the vaccine was stored in freezer and they took out one to two vials and placed in fridge each day as needed.
She reports at first she had a low grade fever , headache, and body aches. Later on that day she felt like she was going to faint. Her blood pressure was 79/58 and heart rate was 104. She had shortness of breath, anxeity, depression, and just felt "odd". She said now she gets short of breath and has a heartburn like pain in the middle of her chest.
Information has been received from a physician concerning a male patient who was vaccinated during routine immigration exams with a dose of Varivax. Subsequently the patient developed a mild to moderate chicken pox-like rash. The lesions were noted to be papules. The patient's outcome was not reported. Further information is not expected.
Patient developed a sore arm the same day and it worsened by Sunday. She developed lymph node swelling under the left arm with pain and tenderness. Patient may have had a fever, but never took her temperature to verify.
Per  MD  note  from  11/10/17:  Patient is a 71 year old man with PMH of OSA and PTSD presenting with several weeks of cough  /  shortness of breath. Later developed acute rash and weakness after flu and PNA vaccines. ROS also positive for new dysuria. Objective findings on presentation to the ED included fever and leukocytosis. Evaluation thus far has not suggested UTI or PNA, with ddx including cellulitis vs. adverse reaction to vaccination. Currently on ceftriaxone for possible cellulitis, while blood cx pending. (Blood cultures were all negative).
she had received the MMR II vaccine (unspecified date) as a child but a recent test revealed that she had not seroconverted; she tested positive to a pregnancy test after receiving the MMR II vaccine; Information has been received from a female patient of unknown age, referring to herself. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not reported. The patient had received the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) vaccine (strength, dose, route, lot # and expiration date were not reported) for prophylaxis on an unspecified date as a child. The patient was pregnant.  On an unknown date (reported as recently), the patient performed a test, which revealed that she had not seroconverted. Subsequently, the patient received a booster shot (one dosage form) of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) vaccine (strength, dose detail, route, lot # and expiration date were not reported) for prophylaxis on 21-FEB-2020.   On the same date, after receiving the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) vaccine, the patient tested positive to a pregnancy test (exposure during pregnancy). The last menstrual period (LMP) and the estimated date of delivery (EDD) were unknown. The pregnancy outcome was outcome pending. The fetal outcome was unknown. There was no treatment received. The patient had sought medical attention. The outcome of seroconversion test negative was unknown. The causality assessment was not provided.
SOB devel about 1hr p/vax;pt was alert but distressed;no wheezing but dusky lips;given epi SC p/given 02 mask; also recv dexamethasone;marked improvement @ 20min;
C/o Tingling in hands, fingers, weakness in legs, mild lightheadedness.  Legs elevated. Reaction time 15 min from Vaccine admin. B/P slightly elevated 144/90...See document. Approached with mild tingling ...., lied down for 10 min. and felt better.  Discharged to self at 7:15pm.
Large patch of redness and rash; This case was reported by a consumer via interactive digital media and described the occurrence of red rash in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced red rash. On an unknown date, the outcome of the red rash was not recovered/not resolved.   It was unknown if the reporter considered the red rash to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 03-JUL-2022. Reporter's Comments: This case was reported by a consumer via interactive digital media The patient had large patch of redness and rash. The patient asked what should he/she do.
Patient requested Janssen vaccine online but due to miscommunication received Moderna vaccine.  First dose of covid vaccine.  No medical adverse events so far reported.
Approx 7d, pain lower back, tingling hands.  Approx 14d, severe back pain & pain shooting up arms & legs & numbness in trunk & same area of pain. Hosp 5 wks-Therapy; Meds at home.unk when reflexs, nerves heal or numbness subsides.  + GBS.
Developed chronic knee pain in right knee, despite losing 180 lbs. Only appeared after vaccine.
heart rate of 173; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (heart rate of 173) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced HEART RATE INCREASED (heart rate of 173). At the time of the report, HEART RATE INCREASED (heart rate of 173) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, Heart rate: 173 (Inconclusive) heart rate of 173.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication use was provided by the reporter.  No treatment of events was reported.
Fever to 102.9 day after shots, vomiting and diarrhea - treated with OTC ADVIL and diet changes for stomach symptoms.
Tiredness; Little headache; Muscle and body pain; Muscle and body pain; Fever; This is a spontaneous report from a contactable consumer (patient). A 33-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686) via an unspecified route of administration on 02Jan2021 at single dose for covid-19 immunisation. The relevant medical history and concomitant medications were reported as none. The day prior to the report on 07Jan2021, the patient got side effects of tiredness, little headache, fever, muscle and body pain. He stated that tiredness began in early morning. He was scheduled to receive second dose on 23Jan2021. He asked a nurse to give him something for a headache the day prior to the report. Since 07Jan2021, he was feeling better. Clarified he cannot confirm the name of medication he was given. He was still feeling body pain. At the time of the report, he asked if he needed to go to the clinic. Didn't know if he needed to wait. Clarified he was asking for medication and if he could go to the hospital to ask for medication. The outcome of the event body pain was not recovered, for the event tiredness and little headache was recovering, while other events were unknown.
Drug Allergies; upset stomach; swelling; Initial information received on 04-Jul-2019 regarding an unsolicited valid non-serious case received from a physician via other company (Pfizer).  This case involves a patient (age and gender unknown) who experienced drug allergies, while he/she received vaccine TETANUS TOXOID.  The patients past medical history, concomitant medication and family history were not provided. At the time of the event, the patient had ongoing Dialysis with prescription of Lyrica 50 mg 1 PO daily post dialysis.   On an unknown date, the patient received a dose of suspect TETANUS TOXOID produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious drug allergies (allergy to vaccine) with unknown latency following the administration of TETANUS TOXOID. On an unknown date, the patient developed a non-serious upset stomach (abdominal discomfort) with unknown latency following the administration of TETANUS TOXOID. On an unknown date, the patient developed a non-serious swelling with unknown latency following the administration of TETANUS TOXOID.  Lab data was not provided.  Final diagnosis was drug allergies.  It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown for drug allergies, as Unknown for upset stomach and as Unknown for swelling.  List of documents held by sender: none. Information batch number was requested for this case.
Patient admitted to hospital complaining of aching and severe pain to upper limbs and trunk. Elevated temperature and elevated WBC. Required treatment with IV Fluids and steroids.
Initial information received on 13-Sep-2018 regarding an unsolicited valid non-serious case received from a consumer/non-HCP. This case involves a 81 years old female patient who had started coughing monday night and has been coughing since the vaccine was administered, while she received vaccine FLUZONE HIGH DOSE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 10-Sep-2018, the patient received a dose of suspect FLUZONE HIGH DOSE (lot number not reported) via intramuscular route in the left arm. On unknown date, the patient developed a non-serious started coughing Monday night and has been coughing since following the administration of FLUZONE HIGH DOSE. Relevant tests were not reported. Final diagnosis was started coughing Monday night and has been coughing since. The patient was treated with DELSYM. The outcome for the event was not reported. List of documents held by sender: none.
stroke; This is a spontaneous report from a non-contactable other hcp  A female patient of an unspecified age received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (at an unspecified age) (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunisation.   The patient medical history and concomitant medications were not reported.  The patient experienced stroke (medically significant) on an unspecified date within 48 hours of her vaccine with outcome of unknown. Therapeutic measures were taken as a result of stroke: fully on anticoagulation. (as reported)  The lot number for [BNT162B2], was not provided and will be requested during follow up; Sender's Comments: Based on the information provided in the narrative, a causal association between the suspect drug and the event cannot be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Red, swelling, itching, warm to touch, raised and textured injection site seven days after injection.